Search
for
Sort by
Research 361–390 of 1000+
- Thrombocytosis Associated with Low-Molecular-Weight Heparin
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- <i>Alpinia zerumbet</i>: A Review of the Chemistry, Quantity, and Pharmacological Properties of Selected Kavalactones
- WNT10B (wingless-type MMTV integration site family)
- FASCE, benefit of spironolactone for treating acne of adult female: study protocol for a randomized double-blind trial
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Diagnosis of common, benign neonatal dermatoses
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Trailing the Path to Preventive Oncology
- The ITGB6 gene: its role in experimental and clinical biology
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- Hepatotoxicity Associated with Anabolic Androgenic Steroids and Selective Androgen Receptor Modulators: A Literature Review
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Dermatologic care of the transgender patient - eScholarship
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Parathyroid Hormone-related Protein in Normal and Neoplastic Canine Tissues: Immunohistochemical Localization and Biochemical Extraction
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Matriptase: Potent Proteolysis on the Cell Surface
- Is Dihydrotestosterone a Classic Hormone?
- Copper-quercetin complexes: methods of study, relevance to cell death pathways, therapeutic applications
- SUN-118 A Case of Anastrozole Induced Hyperandrogenism
- Steroid Hormones of Reproduction and Sexual Development
- ANTIANDROGEN TREATMENT OF POLYCYSTIC OVARY SYNDROME
- ANTIANDROGEN THERAPY IN DERMATOLOGY